AIMC Topic: Chemotherapy, Adjuvant

Clear Filters Showing 1 to 10 of 91 articles

Worse survival despite indolent features for triple-negative invasive lobular carcinoma: a Swedish nationwide registry-based study.

Breast cancer research and treatment
PURPOSE: To evaluate differences in clinical outcomes, treatments received, recurrence, and sociodemographic characteristics in patients with triple-negative breast cancer (TNBC) classified as invasive lobular carcinoma (TNBC-ILC) or invasive carcino...

Genetic algorithm-optimized neural network outperforms TNM staging in predicting rapidly progressive nasopharyngeal carcinoma: Reassessing adjuvant chemotherapy benefit via propensity score matching.

European journal of cancer (Oxford, England : 1990)
PURPOSE: To establish machine learning-based predictive models for rapidly progressive nasopharyngeal carcinoma (RP-NPC), defined as disease progression within 24 months post-initial treatment, and to assess differential survival benefits of adjuvant...

Machine learning and SHAP value interpretation for predicting the response to neoadjuvant chemotherapy and long-term clinical outcomes in Chinese female breast cancer.

Annals of medicine
BACKGROUND: Most models of neoadjuvant chemotherapy (NACT) for breast cancer (BC) suffer from insufficient data and lack interpretability. Additionally, there is a notable absence of reports from China in this field. This study is also the first to i...

Ultrasound-based machine learning models for predicting response to neoadjuvant chemotherapy in breast cancer: A meta-analysis.

Clinical imaging
BACKGROUND AND AIMS: Breast cancer remains the most common cancer among women globally, with neoadjuvant chemotherapy (NAC) serving as a critical pre-surgical intervention. Ultrasound-based radiomics and machine learning (ML) models offer potential f...

Developing a machine-learning model to enable treatment selection for neoadjuvant chemotherapy for esophageal cancer.

Scientific reports
Although neoadjuvant chemotherapy with docetaxel + cisplatin + 5-fluorouracil (CF) has been the standard treatment for stage II and III esophageal cancers, it is associated with severe adverse events caused by docetaxel. Consequently, this study aime...

Predicting the prognosis of radical gastrectomy for patients with locally advanced gastric cancer after neoadjuvant chemotherapy using machine learning technology: a multicenter study in China.

Surgical endoscopy
BACKGROUND: Neoadjuvant chemotherapy (NAC) can improve the prognosis of patients with locally advanced gastric cancer (LAGC). However, precise models for accurate prognostic predictions are lacking. We aimed to utilize Cox regression and integrate va...

Evaluating cell-free DNA integrity index as a non-invasive biomarker for neoadjuvant chemotherapy in colorectal cancer patients.

BMC cancer
BACKGROUND: Neoadjuvant chemotherapy (NAC) is gaining attention as a treatment for advanced colorectal cancer owing to its potential to improve surgical outcomes and prognosis. However, reliable biomarkers to predict the response to NAC are lacking. ...